NYMXF — NYMOX PHARMACEUTICAL CORP COM
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 1 SEC-registered investment managers reported holding NYMXF (NYMOX PHARMACEUTICAL CORP COM) in their latest 13F filings, with a combined reported value of $4.21K across 35.10K shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +71.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Major shareholders of NYMOX PHARMACEUTICAL CORP COM (NYMXF) include Morgan Stanley, Renaissance Technologies, DF DENT & CO INC, ranked by reported 13F value among the 14 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 1 | 35.10K | $1.25K | +0.0% |
| Q2 2026 | 1 | 35.10K | $4.21K | +0.0% |
| Q1 2026 | 1 | 35.10K | $2.46K | +0.0% |
| Q4 2025 | 1 | 35.10K | $1.41K | +0.0% |
| Q3 2025 | 1 | 35.10K | $2.06K | +0.0% |
| Q2 2025 | 1 | 35.10K | $4.13K | +0.0% |
| Q1 2025 | 2 | 110.10K | $15.96K | +0.0% |
| Q4 2024 | 1 | 35.10K | $3.51K | +0.0% |
Over the 8 quarters shown, institutional share counts increased 0% in aggregate (Q4 2024 → Q3 2026).
Top Institutional Holders (Q3 2026) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 35.10K | $1.25K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 35.10K | $4.21K | 0.00% | Hold |
Q1 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 35.10K | $2.46K | 0.00% | Hold |
Q4 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 35.10K | $1.41K | 0.00% | Hold |
Q3 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 35.10K | $2.06K | 0.00% | Hold |
Q2 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 35.10K | $4.13K | 0.00% | Hold |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 14 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First Citizens Financial Corp | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | 35.10K | — | — | — | — | — | — | — |
| DF DENT & CO INC | — | — | — | — | — | — | 75.00K | — | 75.00K | — | 75.00K | — | 75.00K | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | — | — | — | 60.80K | 69.38K | 82.80K | — | 19.74K | — | — |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.30K | 3.30K | 3.10K | 14.49K | — | — | 7.48K |
| One Day In July LLC | — | — | — | — | — | — | — | — | — | — | — | — | 10.00K | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | — | — | — | — | 708 | 708 | 354 | 1.27K | 3.25K | 9.40K | 15.12K |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.47K | 109.08K | — |
| Geode Capital Management | — | — | — | — | — | — | — | — | — | — | — | — | — | 50.68K | 50.68K | 50.68K | 50.68K | 50.68K | 50.68K | 50.68K |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 47.92K | — | 38.07K | — | — | 21.88K |
| UBS Group AG | — | — | — | — | — | — | — | — | — | — | — | — | — | 34.53K | 375 | 375 | 375 | 925 | 550 | 550 |
| Citadel Advisors | — | — | — | — | — | — | — | — | — | — | — | — | — | 30.14K | 72.71K | 99.96K | — | — | 24.94K | — |
| Goldman Sachs Group | — | — | — | — | — | — | — | — | — | — | — | — | — | 22.08K | 19.98K | 19.98K | 21.22K | 23.78K | 23.91K | 24.38K |
| Morgan Stanley | — | — | — | — | — | — | — | — | — | — | — | — | — | 98.69K | 98.69K | 97.62K | 96.57K | 66.42K | 68.27K | 67.10K |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | — | — | — | 10.22K | 7.74K | 9.36K | 9.64K | 9.26K | 11.45K | 12.08K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold NYMXF?
As of 2026-Q2, 1 institutional funds reported holding NYMXF (NYMOX PHARMACEUTICAL CORP COM) in SEC 13F filings, with a combined reported value of $4.21K.
How many shares of NYMXF do institutions own?
13F filers reported 35.10K shares of NYMXF, worth $4.21K in aggregate at the end of 2026-Q2.
Is institutional ownership of NYMXF rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of NYMXF?
The largest 13F holders are Morgan Stanley, Renaissance Technologies, DF DENT & CO INC, Geode Capital Management, UBS Group AG; the top 25 are ranked at the top of this page.
Who are the major shareholders of NYMOX PHARMACEUTICAL CORP COM?
The major shareholders of NYMOX PHARMACEUTICAL CORP COM (NYMXF) by reported 13F value are Morgan Stanley, Renaissance Technologies, DF DENT & CO INC, Geode Capital Management, UBS Group AG, among 14 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.